ursodeoxycholic acid has been researched along with mevalonic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eguchi, K; Hamasaki, K; Ichikawa, T; Ida, H; Kajiya, Y; Kato, Y; Kawakami, A; Nakao, K; Nakata, K; Shigeno, M; Takeda, Y | 1 |
1 other study(ies) available for ursodeoxycholic acid and mevalonic acid
| Article | Year |
|---|---|
Geranylgeraniol, an intermediate product in mevalonate pathway, induces apoptotic cell death in human hepatoma cells: death receptor-independent activation of caspase-8 with down-regulation of Bcl-xL expression.
Topics: Apoptosis; bcl-X Protein; Carcinoma, Hepatocellular; Caspase 3; Caspase 8; Caspase 9; Caspase Inhibitors; Caspases; Cysteine Proteinase Inhibitors; Diterpenes; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Mevalonic Acid; Neoplasm Proteins; Oligopeptides; Proteins; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Tumor Cells, Cultured; Ursodeoxycholic Acid; X-Linked Inhibitor of Apoptosis Protein | 2001 |